Efficacy of intravitreal bevacizumab on diabetic macular oedema in an African population.
Samuel KyeiFrederick Afum AsareJohn Kwesi AssanEbenezer ZaabaarFrank AssiamahEric Obour ObengKofi AsieduPublished in: Irish journal of medical science (2023)
Treatment with intravitreal bevacizumab injection produces short-term improvement in vision and reduction in central macular thickness in African patients with diabetic macular oedema.